Literature DB >> 34595739

A Brief History and the Significance of the GABAB Receptor.

Styliani Vlachou1.   

Abstract

γ-Aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the brain. GABA type B (GABAB) receptors (GABABRs) are the only metabotropic G protein-coupled receptors for GABA and can be found distributed not only in the central nervous system, but also in the periphery. This chapter introduces important, fundamental knowledge related to GABABR function and the various potential therapeutic applications of the development of novel GABABR-active compounds, as documented through extensive studies presented in subsequent chapters of this Current Topic in Behavioral Neurosciences volume on the role of the neurobiology of GABABR function. The compounds that have received increased attention in the last few years compared to GABABR agonists and antagonists - the positive allosteric modulators - exhibit better pharmacological profiles and fewer side effects. As we continue to unveil the mystery of GABABRs at the molecular and cellular levels, we further understand the significance of these receptors. Future directions should aim for developing highly selective GABABR compounds for treating neuropsychiatric disorders and their symptomatology.
© 2021. Springer Nature Switzerland AG.

Entities:  

Keywords:  Animal models; Cognition; Drug and alcohol addiction; GABAB receptors; Humans; Neurochemistry; Neurodegeneration; Neurodevelopmental disorders; Pharmacology; Pharmacotherapy; Treatment

Mesh:

Substances:

Year:  2022        PMID: 34595739     DOI: 10.1007/7854_2021_264

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  92 in total

Review 1.  Molecular structure and physiological functions of GABA(B) receptors.

Authors:  Bernhard Bettler; Klemens Kaupmann; Johannes Mosbacher; Martin Gassmann
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

Review 2.  [GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators].

Authors:  Roberta Agabio; Giancarlo Colombo
Journal:  Psychiatr Pol       Date:  2015 Mar-Apr       Impact factor: 1.657

Review 3.  Measuring GABAergic inhibitory activity with TMS-EEG and its potential clinical application for chronic pain.

Authors:  Mera S Barr; Faranak Farzan; Karen D Davis; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-29       Impact factor: 4.147

Review 4.  Translational gastrointestinal pharmacology in the 21st century: 'the lesogaberan story'.

Authors:  Guy E Boeckxstaens; Hans Denison; Jörgen M Jensen; Anders Lehmann; Magnus Ruth
Journal:  Curr Opin Pharmacol       Date:  2011-10-27       Impact factor: 5.547

5.  GABA-producing Lactobacillus plantarum inhibits metastatic properties and induces apoptosis of 5-FU-resistant colorectal cancer cells via GABAB receptor signaling.

Authors:  JaeJin An; Heon Seok; Eun-Mi Ha
Journal:  J Microbiol       Date:  2021-02-01       Impact factor: 3.422

Review 6.  GABA (γ-aminobutyric acid), a non-protein amino acid counters the β-adrenergic cascade-activated oncogenic signaling in pancreatic cancer: a review of experimental evidence.

Authors:  Hussein A N Al-Wadei; Mohammad F Ullah; Mohammed Al-Wadei
Journal:  Mol Nutr Food Res       Date:  2011-08-01       Impact factor: 5.914

Review 7.  Efficacy and tolerability of baclofen in substance use disorders: a systematic review.

Authors:  Roberta Agabio; Antonio Preti; Gian Luigi Gessa
Journal:  Eur Addict Res       Date:  2013-06-15       Impact factor: 3.015

8.  Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.

Authors:  K L Allen; H J Waldvogel; M Glass; R L M Faull
Journal:  J Chem Neuroanat       Date:  2009-02-21       Impact factor: 3.052

Review 9.  Rational approaches for the design of various GABA modulators and their clinical progression.

Authors:  Kavita Bhagat; Jatinder V Singh; Piyusha P Pagare; Nitish Kumar; Anchal Sharma; Gurinder Kaur; Nihar Kinarivala; Srinivasa Gandu; Harbinder Singh; Sahil Sharma; Preet Mohinder S Bedi
Journal:  Mol Divers       Date:  2020-03-13       Impact factor: 2.943

10.  Mechanisms underlying the enhancement of γ-aminobutyric acid responses in the external globus pallidus of R6/2 Huntington's disease model mice.

Authors:  Joshua Barry; Theodore A Sarafian; Joseph B Watson; Carlos Cepeda; Michael S Levine
Journal:  J Neurosci Res       Date:  2020-08-27       Impact factor: 4.433

View more
  1 in total

Review 1.  Function of the GABAergic System in Diabetic Encephalopathy.

Authors:  Hongli Zhou; Zhili Rao; Zuo Zhang; Jiyin Zhou
Journal:  Cell Mol Neurobiol       Date:  2022-04-23       Impact factor: 5.046

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.